Long-Term Use of Tamoxifen Is Associated With a Decreased Subsequent Meningioma Risk in Patients With Breast Cancer: A Nationwide Population-Based Cohort Study.

Front Pharmacol · 2019 · PMC6582668 · PMID 31249531

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

Although the current study could not conclusively establish that for breast patients, tamoxifen treatment significantly decreases the risk of subsequent meningioma compared with non-tamoxifen treatment, the results were borderline significant, with a direction (protective role) consistent with their findings.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.